Receptors are cellular components that trigger internal changes based on external signals. Researchers have built a new synthetic receptor with incredibly broad potential to program cell activity, ...
The gross proceeds to the Company from the offering are approximately $2.8 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. Purple Biotech ...
DPX Formulations Superior to Mixing with Commonly Used Adjuvants DPX Without Antigen Cargo Has Immune Stimulating Properties Unique Potential for DPX in New Fields of Use VANCOUVER ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer ...